发明名称 |
VACCINES COMPRISING TRUNCATED HBC CORE PROTEIN PLUS SAPONIN-BASED ADJUVANTS |
摘要 |
<p>Composition (A) comprises (i) one or more hepatitis B core antigens (HBcAg) containing amino acids 1 to x (x = 100-160),their fragments, variants of fragment variants; (ii) an adjuvant containing a saponin and/or saponin derivative; and (iii) optionally, one or more hepatitis B surface antigens (HBsAg), or their fragments, variants or variant fragments. ACTIVITY : Virucide; Hepatotropic; Antiinflammatory. Mice were immunized with a composition containing 5 mu g AbISCO-200 (RTM for a saponin composition) and 10 mu g HBcAg1-144+1 in 0.1 ml phosphate-buffered saline. The number of CD8 +> cells that expressed gamma -interferon was just over 100 per 10 5> such cells; compared with zero when the same antigen was administered without saponin. When the composition also contained 5 mu g HBsAg, the number of such cells was 170/10 5>. The composition also resulted in high levels of immunoglobulins G1 and G2b, indicating a Th1/Th2 response. MECHANISM OF ACTION : Vaccine.</p> |
申请公布号 |
EP1924597(A2) |
申请公布日期 |
2008.05.28 |
申请号 |
EP20060792095 |
申请日期 |
2006.09.15 |
申请人 |
RHEIN BIOTECH GESELLSCHAFT FUER NEUE BIOTECHNOLOGISCHE PROZESSE UND PRODUKTE MBH |
发明人 |
MELBER, KARL;BUCHMANN, PASCALE;JANOWICZ, ZBIGNIEW |
分类号 |
C07K14/02;A61K39/39;A61P31/04 |
主分类号 |
C07K14/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|